• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Podcast » Topiramate and Adderall Reduce Cocaine Use [60 Sec Psych]

The Carlat Psychiatry Podcast
The Carlat Psychiatry Podcast RSS FeedRSS

Clear, engaging, and practical updates on clinical psychiatry.
Earn CME for listening to the podcast with a Podcast CME Subscription.
Listen for free here or using Apple Podcasts and Spotify.

Topiramate and Adderall Reduce Cocaine Use [60 Sec Psych]

August 8, 2020


We always say that single positive studies need replication, and here comes one. In 2012 a randomized trial found that the combination of topiramate and adderall xr worked better than placebo at helping people with frequent cocaine use stay sober. This new study [Link] sought to replicate that, although it was by the same research group as the original─Columbia’s New York State Psychiatric Institute. The new addition is a larger study looked at 127 patients over 3 months.

Published On: 8/8/20


Duration: 2 minutes, 16 seconds


Transcript:

We always say that single positive studies need replication, and here comes one. In 2012 a randomized trial found that the combination of topiramate and adderall xr worked better than placebo at helping people with frequent cocaine use stay sober. This new study sought to replicate that, although it was by the same research group as the original ─ Columbia’s New York State Psychiatric Institute. The new addition is a larger study looked at 127 patients over 3 months.


This was a double-blind, randomized placebo-controlled trial, that tested Adderall XR combined with topiramate against placebo. Like the earlier study, the treatment worked on the primary measure – how many patients stayed sober for at least 3 weeks. None on the placebo achieved that, but 14% on the treatment did.


1 in 5 patients had to stop the treatment due to elevated blood pressure or pulse. Otherwise, they were well tolerated.


Which begs the question, why not use topiramate on its own? Topiramate does have promising pilot studies on its own, as does Adderall ─ though that particular study was in people with ADHD who used cocaine. But clinically I would start with the less risk of the two ─ topiramate ─ before considering the combination.


Topiramate was titrated over 6 weeks to a max of 100 mg bid and adderall XR over 2 weeks to a max of 60mg/day.  The authors suggest the cardiovascular risks may have been lessened if adderall was titrated slower.


Got feedback? Take the podcast survey.
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.